Cancer News and Research

Latest Cancer News and Research

NYBC ends emergency appeal for blood donations

Thanks to the support of blood donors – who answered the emergency call after winter snowstorms drove blood supplies to critical levels – New York Blood Center is ending its emergency appeal for blood donations and returning to its normal collection schedule. The supply of several blood types, including O-negative blood, has returned to recommended 3-5 day inventory levels.

10 Feb 2011

WIN Consortium proposes unique alliance to fight cancer

WIN Consortium proposes a unique alliance to fight cancer and invites you to join the 3rd annual symposium: Gateways to efficacy of cancer diagnostics and therapeutics to be held on 6th to 8th of July at the Palais des Congrès in Paris, France.

10 Feb 2011

L-methylfolate in combination with antidepressant drug helps major depressive disorder patients

Data published in the January issue of Innovations in Clinical Neuroscience, www.psychiatrymmc.com, suggest when L-methylfolate, a medical food available commercially as Deplin®, and by prescription, is used for dietary management of depression in combination with an antidepressant drug at the start of depression therapy, it results in significantly more patients experiencing major improvement and more rapid improvement than antidepressant monotherapy alone.

10 Feb 2011

Pediatricians can play a key role in promoting tobacco-free lifestyle among children, adolescents

Nicotine addiction usually begins during the critical teenage years, and pediatric healthcare professionals can play a prominent role in promoting a tobacco-free lifestyle among children and adolescents, as described in an article published online ahead of print in Pediatric Allergy, Immunology, & Pulmonology, a peer-reviewed journal published by Mary Ann Liebert, Inc.

10 Feb 2011

Study shows pregnant teens have aspirations to continue education, pursue careers

The United States has the highest adolescent pregnancy and birth rate among developed countries in the world. Many mistakenly believe that teens who become pregnant do not have aspirations of going to college or finding a good job.

10 Feb 2011

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.

From BD (Becton, Dickinson and Company) 10 Feb 2011

Myriad Genetics' 46-gene PROLARIS molecular diagnostic test predicts prostate cancer outcome

Myriad Genetics, Inc. announced today that a study published in Lancet Oncology shows the Company's 46-gene PROLARIS™ molecular diagnostic test significantly predicts prostate cancer outcome.

10 Feb 2011

Everolimus phase III study shows improved progression-free survival in patients with pNET

In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin, has shown to dramatically improve progression-free survival for patients with advanced pancreatic neuroendocrine tumors, according to researchers from The University of Texas MD Anderson Cancer Center.

9 Feb 2011

Seaweed microsponges may help diagnose many diseases quickly, at far lower cost

Microsponges derived from seaweed may help diagnose heart disease, cancers, HIV and other diseases quickly and at far lower cost than current clinical methods. The microsponges are an essential component of Rice University's Programmable Bio-Nano-Chip (PBNC) and the focus of a new paper in the journal Small.

9 Feb 2011

Evotec signs definitive agreement to acquire all shares in Kinaxo

Evotec AG today announced the signing of a definitive agreement to acquire all shares in Kinaxo Biotechnologies GmbH, a Munich-based drug discovery alliance company supporting the development of targeted drugs.

9 Feb 2011

PBNC technology may help detect cardiac disease, reduce diagnostic costs

Heart disease is a silent killer, but new microchip technology from Rice University is expected to advance the art of diagnosis.

9 Feb 2011

NCCN praises Aetna for evidence-based approach to treat cancer

The National Comprehensive Cancer Network® (NCCN) has praised Aetna for its evidence-based approach to drugs used to treat cancer. The NCCN also acknowledged Aetna's commitment to providing health benefits to members enrolled in clinical trials. Aetna is the first national health plan to be recognized by the group.

9 Feb 2011

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

CeNeRx BioPharma, Inc., a clinical-stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced FDA approval of its IND and reported the first clinical results in humans for CXB909, a novel agent that has demonstrated utility in preclinical models of neuroprotection and neurodegenerative disorders.

9 Feb 2011

DiaTech, Walter Reed collaborate to determine the best chemotherapy for cancer

DiaTech Oncology announced today they have engaged in a pilot with Walter Reed Army Medical Center to determine the best Chemotherapy for Cancer patients. Medical and GYN Oncologists and from Walter Reed have been working with DiaTech Oncology (Nashville, TN) using the MiCK assay for apoptosis in order to give physicians a tool that can predict the best chemotherapy pathway in treating cancer patients.

9 Feb 2011

Kaiser Permanente Southern California selected for 10-center Mental Health Research Network

The Kaiser Permanente Southern California Department of Research & Evaluation has been selected for inclusion in the 10-center Mental Health Research Network (MHRN) recently funded with a $10.5 million grant from the National Institute of Mental Health. The five other Kaiser Permanente research centers included in the MHRN are located in Northern California, Oregon, Colorado, Georgia, and Hawaii.

9 Feb 2011

Funding too low for paediatric oncology research

At a time when the effects of paediatric oncology research have meant that more and more children survive cancer, its funding is too low and dependent on short-term grants to be able to sustain this improvement in the long-term, says a report supported by the EU-funded 7th Framework Programme project Eurocancercoms and published on-line in ecancer today.

9 Feb 2011

Topical cream used to treat skin diseases activates two distinct neuronal signaling pathways

Scratching deep beneath the surface, a team of researchers from the University of California, San Diego School of Medicine and three South Korean institutions have identified two distinct neuronal signaling pathways activated by a topical cream used to treat a variety of skin diseases. One pathway produces the therapeutic benefit; the other induces severe itching as a side effect.

9 Feb 2011

Men with high levels of CCP genes more likely to have fatal form of prostate cancer

A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published1 in the Lancet Oncology.

9 Feb 2011

Life Sciences Discovery Fund announces nearly $600,000 in awards

The Life Sciences Discovery Fund (LSDF) today announced nearly $600,000 in awards to support commercial development of technologies to improve the diagnosis and management of major health conditions.

9 Feb 2011

Study finds breast cancer patients do not benefit from axillary lymph node dissection

Among patients with early-stage breast cancer that had spread to a nearby lymph node and who received treatment that included lumpectomy and radiation therapy, women who just had the sentinel lymph node removed did not have worse survival than women who had more extensive axillary lymph node dissection, according to a study in the February 9 issue of JAMA.

9 Feb 2011

Cancer News and Research

Latest Cancer News and Research

NYBC ends emergency appeal for blood donations

WIN Consortium proposes unique alliance to fight cancer

L-methylfolate in combination with antidepressant drug helps major depressive disorder patients

Pediatricians can play a key role in promoting tobacco-free lifestyle among children, adolescents

Study shows pregnant teens have aspirations to continue education, pursue careers

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

Myriad Genetics' 46-gene PROLARIS molecular diagnostic test predicts prostate cancer outcome

Everolimus phase III study shows improved progression-free survival in patients with pNET

Seaweed microsponges may help diagnose many diseases quickly, at far lower cost

Evotec signs definitive agreement to acquire all shares in Kinaxo

PBNC technology may help detect cardiac disease, reduce diagnostic costs

NCCN praises Aetna for evidence-based approach to treat cancer

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

DiaTech, Walter Reed collaborate to determine the best chemotherapy for cancer

Kaiser Permanente Southern California selected for 10-center Mental Health Research Network

Funding too low for paediatric oncology research

Topical cream used to treat skin diseases activates two distinct neuronal signaling pathways

Men with high levels of CCP genes more likely to have fatal form of prostate cancer

Life Sciences Discovery Fund announces nearly $600,000 in awards

Study finds breast cancer patients do not benefit from axillary lymph node dissection

Cancer Research - Second Edition eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in